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Proliferation—that is, progression through the cell cy-
cle—and apoptosis are opposing cellular mechanisms,
one leading to multiplication and the other to elimina-
tion of cells. Although proliferation and apoptosis can
function independently of each other, the two pathways
are often linked in mammalian cells. For example, cell-
cycle checkpoints control the initiation, progression, and
completion of the cycle, giving cells a chance to correct
mistakes before continuing with subsequent steps of the
cycle. However, if the mistakes are not correctable, the
cells are eliminated by execution of apoptosis. The in-
tegration of these two seemingly conﬂicting pathways is
a useful strategy in multicellular organisms, in which
cells can be replaced readily but in which the pro-
liferation of potentially tumorigenic cells must be
suppressed.
Because of the link between cell-cycle and apoptotic
pathways, it is not surprising that proteins that play a
role in both mechanisms are associated with, and may
cause, cancer. One well-known example is the P53 gene,
which acts in the G1 checkpoint of the cell cycle and is
also necessary for apoptosis (Liebermann et al. 1995;
Agarwal et al. 1998). Many cancers, inherited or spo-
radic, involve loss of p53 function. Another example is
theMYC oncogene, which stimulates proliferation at the
G1rS transition in the cell cycle and simultaneously
causes cells to be very sensitive to apoptosis (Evan et al.
1992).
Like p53 and Myc, the recently discovered cellular
apoptosis–susceptibility (CAS) protein, the human ho-
mologue of the yeast chromosome-segregation protein
CSE1 (Xiao et al. 1993; Brinkmann et al. 1995a, 1995b,
1996a, 1996b), is associated with both apoptosis and
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cell proliferation and also appears to play a role in can-
cer. Interestingly, unlike most well-known cancer genes,
which function in the G1rS transition of the cell cycle,
CAS is necessary in a mitotic checkpoint that may assure
the accurate segregation of chromosomes.
A cell-cycle checkpoint that permits chromosome seg-
regation only if all chromosomes are properly aligned
has been established, in part, through direct microma-
nipulation of chromosomes in insect cells (Nicklas
1997). However, in contrast to the vast amount of
knowledge available regarding the G1rS checkpoint and
the role of oncogenes in overriding it, knowledge of the
molecular basis of the mitotic checkpoint is only now
emerging. This checkpoint is probably crucial in the de-
velopment of human cancer: Genomic instability is one
hallmark of cancer, and a major mechanism by which
the genome of cancer cells becomes unstable may be the
overriding of cell-cycle checkpoints that are responsible
for accurate chromosome maintenance. In this article, I
discuss the evidence that the human CAS gene, like the
yeast chromosome-segregation gene CSE1, is involved
directly or indirectly in the spindle checkpoint. The fact
that CAS is also associated with apoptosis suggests that
it could be a safeguard against genomic instability, par-
ticipating in apoptosis when correct chromosome seg-
regation cannot be achieved.
CAS in Apoptosis and Proliferation
The CAS gene was originally identiﬁed in a genetic
screen for genes that affect the sensitivity of breast cancer
cells toward toxins and immunotoxins that are used in
experimental cancer therapy (Brinkmann et al. 1995a,
1995b, 1996a). Using an expression-selection cloning
approach, we sought plasmids that would render breast
cancer cells resistant to immunotoxins. Several of the
identiﬁed plasmids contained CAS antisense cDNA frag-
ments, suggesting that the CAS protein participates in
immuntoxin-dependent cytotoxicity. The attenuation of
CAS protein, by expression of antisense cDNA, reduced
the sensitivity of the cells to apoptosis induced by im-
munotoxins and various bacterial toxins (Brinkmann et
al. 1996a) or by tumor-necrosis factor (TNF)–a or TNF-
510 Am. J. Hum. Genet. 62:509–513, 1998
Figure 1 Role of CAS in apoptosis. MCF-7 breast cancer cells
were transfected with a CAS-antisense plasmid or with control plas-
mids and then were exposed to 1 mg TNF-a/ml for 24 h. Antisense-
mediated depletion of CAS protein rendered the cells less sensitive to
TNF-induced apoptosis. In a similar manner, cells also become resis-
tant to apoptosis induced by Pseudomonas exotoxin A and by diph-
theria toxin.
b (ﬁg. 1). Recent observations have indicated that the
apoptotic pathway that is induced by bacterial toxins
depends on the caspase CPP32 (A. Hafkemeyer, U.
Brinkmann, and I. Pastan, unpublished data), and at
least some of the steps in this pathway also occur during
TNF-a–induced apoptosis. Since CAS depletion was
shown to prevent apoptosis, we concluded that CAS
expression is necessary for apoptosis.
CAS is highly homologous to yeast CSE1, an essential
gene that is necessary for accurate chromosome segre-
gation in mitosis (Xiao et al. 1993; Brinkmann et al.
1995a; Irniger et al. 1995). Conditionally lethal CSE1
mutants show a chromosome-segregation–defectivephe-
notype at the nonpermissive temperature, and they are
unable to degrade the cyclin B protein, in which pro-
teolysis represents a key checkpoint in mitosis. There-
fore, CSE1-mutant yeast cells become arrested in mi-
tosis. Because the yeast genome is known completely and
because no other yeast gene has a similarly high ho-
mology to CAS, CSE1 can be considered the functional
yeast counterpart of CAS. The high homology of CAS
to this yeast cell-cycle gene and the observation thatCAS
is highly expressed in proliferating cells but is expressed
only at low levels in most quiescent cells and tissues
suggest that CAS acts not only in apoptosis but also in
the cell cycle. Indeed, we found that CAS is required for
the mitotic checkpoint in the mammalian cell cycle—that
is, the same checkpoint where CSE1 acts in yeast (Ogry-
zko et al. 1997). As withCSE1mutations, CAS depletion
causes accumulation of cyclin B in the cell-cycle–arrested
cells. Conversely, overexpression of CAS is associated
with rapid cell growth, malignant transformation, and
possibly with defects in a mitotic checkpoint that assures
accurate chromosome segregation.
The Molecular Function and Regulation of CAS
One mechanism by which CAS affects proliferation
as well as apoptosis is its function as a nuclear-transport
factor. CAS mediates nuclear-to-cytosolic recycling of
importin-a and possibly other factors that mediate the
transport of speciﬁc proteins into the nucleus (Kutay et
al. 1997; Ullman et al. 1997). Some proteins that enter
the nucleus by the importin pathway are necessary for
the execution of and/or progression through mito-
sis—for example, cyclin-dependent kinases (CDKs) and
cyclin/CDK complexes, kinases, p53, and transcription
factors (retinoblastoma gene product and nucleus factor
kB) (Gallant et al. 1995; Thomas et al. 1996; Middeler
et al. 1997). This explains the observation that depletion
of CAS protein causes a cell-cycle arrest in the G2 phase.
Nuclear transport also appears to be important for
apoptosis. For example, transcription factors, p53, and
probably nucleases need to be transported into the nu-
cleus during apoptosis. Therefore, the involvement of
the CAS protein in apoptosis can be explained by the
requirement of CAS for nuclear transport of proteins
that are necessary for induction and/or execution of
apoptosis.
How is the dual function of CAS in proliferation and
apoptosis regulated? Central regulatory pathways, such
as the mitogen-activated protein (MAP)-kinase cascade,
regulate proliferation as well as apoptosis (Seger and
Krebs 1995). For example, the well-known oncoprotein
Myc, which is a player in theMAP-kinase pathway, stim-
ulates cell proliferation and simultaneously sensitizes
cells to apoptosis (Evan et al. 1992). CAS is also linked
to the MAP-kinase cascade because it contains, at its N-
terminus, a phosphorylation site for MEK, a kinase that
acts upstream of the MAP kinase, in this pathway. It is
likely that the function of CAS is regulated by phos-
phorylation. Recent data indicate that MEK phosphor-
ylation determines whether CAS localizes predominantly
in the cytoplasm or in the nucleus. In turn, this control
of intracellular localization would directly affect the nu-
clear-transport function of CAS and, hence, indirectly
affect that of the importin proteins.
Although the CAS protein needs to be in the nucleus
to perform its nuclear-transport function, in most cells,
the majority of CAS protein is found in the cytoplasm,
where it is associated with microtubules (Scherf et al.
1996). The association of CAS with cytoplasmic micro-
tubules may create a reservoir of inactive CAS protein;
alternatively, microtubule-associated CAS may have dis-
tinct biological functions during interphase. In meiosis
and mitosis, CAS is strongly associated with centrioles
and with the mitotic spindle. It is particularly interesting
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Figure 2 Immunohistological detection of CAS protein in human tumors. Immunohistochemistry with anti-CAS antibodies, which stained
brown or red, shows that CAS protein is abundant in the malignant cells of various tumors, including leukemias (e.g., follicular lymphoma;
left), hepatocarcinoma (middle), and malignant melanoma (right).
that MEK, which phosphorylates CAS and controls its
intracellular localization, also localizes to the spindle and
is involved in a checkpoint that permits mitosis only if
all chromosomes are properly aligned (Nicklas 1997).
The observation of chromosome-segregation defects in
yeast cells that lack CSE1 function (Xiao et al. 1993)
strengthens the possibility that human CAS participates
in a mitotic checkpoint that assures proper chromosome
segregation.
CAS and Cancer
CAS is located on human chromosome 20q13 (Brink-
mann et al. 1996b), a region with a remarkable degree
of instability in various tumors. Ampliﬁcations of
20q13, consisting of several independent amplicons,
with CAS present in one of them (Tanner et al. 1994),
are observed frequently in aggressive types of breast can-
cer. CAS and 20q13 ampliﬁcations also are frequent in
colon cancer (Ried et al. 1996) and in transformed uroe-
pithelial cells, in which these ampliﬁcations correlate
with, and may be causative for, a high degree of genetic
instability (Savelieva et al. 1997).
CAS expression (mRNA and protein) appears to be
generally upregulated in a variety of cancers, not only
in tumors that contain ampliﬁcations of the CAS gene.
Immunohistochemistry with anti-CAS antibodies con-
ﬁrms that the expression of CAS correlates with the de-
velopment of cancer (ﬁg. 2; also see Wellmann et al.
1997). A comparison of CAS expression in different dis-
ease stages demonstrates that increased levels of CAS
coincide with disease progression, suggesting that the
evaluation of CAS expression by immunohistochemistry
or by PCR may be a useful diagnostic tool.
There are at least two mechanisms, which are not
mutually exclusive, by which CAS could induce or ad-
vance tumorigenesis. First, overexpression of CAS (e.g.,
owing to gene ampliﬁcation) may interfere with the
strictly regulated nuclear transport of potential onco-
genes or tumor suppressors. It is striking in this context
that many cancer-associated proteins require highly reg-
ulated nuclear transport. Changes in the nuclear-trans-
port pattern of proteins such as p53, the retinoblastoma
protein, and BRCA1 (Thomas et al. 1996; Middeler et
al. 1997; Wang et al. 1997) are associated with the de-
velopment of cancer. Furthermore, inDrosophila,which
can serve as a model for both normal developmental
pathways and tumorigenesis (St. John and Xu 1997;
Rodriguez et al. 1998 [in this issue]), the pendulin gene
has been identiﬁed as a tumor suppressor; pendulin en-
codes the ﬂy homologue of importin-a, a nuclear shut-
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tling factor that interacts directly with CAS (Kussel and
Frasch 1995). This strongly supports the hypothesis that
interference with the nuclear-transport function of CAS
may play a role in cancer. Second, as suggested by the
chromosome-segregation phenotype of CSE1 yeast cells,
CAS depletion (and probably overexpression) may lead
to the aneuploidy often seen in advanced tumor cells. In
normal yeast and mammalian cells, the spindle check-
point assesses the alignment of chromosomes on the
spindle and allows execution of mitosis only when the
correct distribution of chromosomes into the daughter
cells is possible (Nicklas 1997). Cells with improperly
aligned chromosomes are arrested until the chromo-
somes realign in a correct manner. If correct chromo-
some realignment is not possible, the arrested cells even-
tually die. Recent work with human cells conﬁrms this
view. Schaar et al. (1997) used antibodies or dominantly
acting mutant proteins to block mitosis, by inhibiting
the kinetochore-based motor protein, centromere pro-
tein-E. They found that chromosomes in treated cells
formed but failed to localize to the spindle equator, often
oscillating around it for many hours. Eventually, how-
ever, all these cells underwent sudden death by apoptosis,
as is expected when the mitotic checkpoint is engaged
and cannot be released.
Yeast, a single-celled eukaryote, lacks a mechanism
for apoptosis, but other aspects of the cellular response
to chromosomal misalignment are similar in yeast and
in human cells. Yeast CSE1 mutants show genetic in-
stability, such as aberrant chromosome segregation in
mitosis, and undergo arrest during cell division, much
like CAS-depleted human cells (Xiao et al. 1993). In
addition, genomic instability (e.g., in transformed uroe-
pithelial cells) has been directly associated with ampli-
ﬁcation of the 20q13 region that contains the CAS gene.
This chromosomal 20q13 region contains at least one
gene that is involved in maintaining genome integrity,
including theCAS candidate gene (Savelieva et al. 1997).
Because CAS is associated with the mitotic spindle, it is
possible that CAS is part of the cell-cycle checkpoint
that assures that each daughter cell obtains a complete
set of chromosomes. High constitutive expression of
CAS might then interfere with or override that check-
point. The fact that CAS is also associated with apop-
tosis suggests that it serves as a safeguard against the
consequences of genomic instability, by rendering cells
that might gain or lose chromosomes particularly prone
to apoptosis.
Prospects
In addition to the insights CAS provides into connec-
tions between nuclear-protein transport, cell-cycle
checkpoints, and apoptosis, one major point of interest
is the connection of CAS with cancer and possibly with
other diseases. To date, no inherited defects or aberra-
tions of the CAS gene have been correlated with human
diseases. Since CAS functions in apoptosis as well as in
proliferation—two processes that act together to assure
normal development—one would expect true null alleles
of CAS to cause embryonic lethality. Indeed, the yeast
homologue CSE1 is an essential gene, and mutations in
pendulin, an importin-a homologue that almost cer-
tainly acts in an equivalent nuclear-transport pathway
in ﬂy cells, not only displays aberrant cell proliferation
and tumors but ultimately causes the death of Dro-
sophila larvae (Kussel and Frasch 1995). CAS has yet
to be identiﬁed in Drosophila, but this may prove to be
a useful system for analysis of the consequences of weak
or overexpressed alleles of this gene. CAS mutations, in
humans or in ﬂies, could interfere with regulated import
of nuclear proteins and might lead to developmental
abnormalities and to loss of ﬁdelity in chromosomal dis-
junction, in somatic or germ-line cells.
Sporadic CAS aberrations, particularly ampliﬁcations
of CAS and of the chromosome 20q13 region that har-
bors it, are observed frequently in human tumors, such
as breast cancer and colon cancer, and ampliﬁcations of
this region correlate with aggressive disease (Tanner et
al. 1994; Brinkmann et al. 1996b; Ried et al. 1996;
Savelieva et al. 1997). The observation of very high CAS-
protein levels in other neoplasms, without gene ampli-
ﬁcation, and the fact that increased expression correlates
with the progression of malignancy also suggest the pos-
sibility of mutations that upregulate the expression of
CAS. The analysis of whether and how CAS contributes
to the progression of cancer is the focus of our present
research.
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